Welcome to our dedicated page for Docusign SEC filings (Ticker: DOCU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission (SEC) filings for Docusign, Inc. (NASDAQ: DOCU), a software company focused on digital agreements, eSignature, and Intelligent Agreement Management (IAM). Through these filings, investors can review the company’s official disclosures on financial performance, risk factors, governance, and key business developments.
Annual reports on Form 10-K typically include detailed discussions of DocuSign’s business, including its IAM platform, eSignature and contract lifecycle management offerings, customer base, and the risks and opportunities associated with its operations. Quarterly reports on Form 10-Q provide interim financial statements, management’s discussion and analysis, and updates on metrics such as revenue, subscription trends, billings, and cash flows.
Current reports on Form 8-K disclose material events, such as quarterly financial results and certain corporate governance changes. For example, DocuSign has used Form 8-K to report financial results for specific quarters and to announce board appointments and leadership roles. These filings help investors track significant developments between regular reporting periods.
Other filings, such as proxy statements and any Form 4 insider transaction reports, can offer additional insight into executive and director compensation, equity awards, and share ownership, as well as governance practices. Together, these documents form the regulatory record of DOCU as a Nasdaq-listed issuer.
On Stock Titan, SEC filings for DOCU are updated from the EDGAR system, and AI-powered summaries can assist readers by highlighting key points from lengthy documents like 10-Ks and 10-Qs. This can help users quickly understand DocuSign’s reported results, non-GAAP metrics, and material events without reading every page of each filing.
DOCUSIGN, INC. director Mary Agnes Wilderotter exercised stock options and sold shares in a routine transaction. She exercised options for 3,000 shares of Common Stock at an exercise price of $17.66 per share, then sold 3,000 shares at $48.15 per share on the same date.
After these transactions, she directly held 59,803 shares of DocuSign common stock. The derivative position tied to this specific option grant was fully exercised, with no remaining options from this grant shown in the filing.
DOCUSIGN, INC. Chief Revenue Officer Paula Hansen reported open-market sales of 6,000 shares of common stock on April 1, 2026. The transactions were executed under a pre-arranged Rule 10b5-1 trading plan, with sale prices ranging from about $45.85 to $48.00 per share. Following these sales, Hansen directly holds 79,233 shares of DocuSign common stock, indicating she retained a substantial equity position after the trades.
DOCUSIGN, INC. Chief Legal Officer James P. Shaughnessy reported selling a total of 12,000 shares of common stock in open-market transactions on April 1, 2026. The sales included 5,419 shares at $46.22, 6,481 shares at $47.33, and 100 shares at $48.00 per share. These transactions were executed under a pre-arranged Rule 10b5-1 plan, and following the sales he directly holds 53,631 shares of DocuSign common stock.
DOCUSIGN, INC. President and CEO Allan C. Thygesen sold 26,250 shares of Common Stock in three open-market transactions on April 1 pursuant to a pre-arranged Rule 10b5-1 plan. Sale prices ranged from about $45.89 to $48.38 per share, and he continues to hold 152,237 shares directly.
Morgan Stanley Smith Barney LLC reported a Rule 144 notice showing the sale of 26,250 shares of Common stock by Allan Thygesen under a 10b5-1 plan. The filing lists the sale date as 01/09/2026 and a reported proceeds figure of $1,827,036.75.
The entry references Restricted Stock Units vested on 04/10/2025 and includes a filing date of 04/01/2026.
James P. Shaughnessy reported the sale of 12,000 shares of Common Stock. The filing shows 12,000 shares were sold on 01/02/2026 for $804,394.80. The record also lists 12,000 Restricted and Performance Shares dated 01/10/2025 attributed to the issuer.
Morgan Stanley Smith Barney LLC submitted a Form 144 notice concerning proposed sales of common stock related to DOCU. The filing lists a sale of 6,000 shares on 01/02/2026 valued at $402,293.40 and shows awards of 3,000 performance shares (06/10/2025) and 3,000 restricted stock (08/10/2025).
DocuSign Inc amendment to a Schedule 13G/A states 0 shares beneficially owned and 0% of the class by The Vanguard Group as reported in this filing. The filing explains an internal realignment on January 12, 2026 that led certain Vanguard subsidiaries and business divisions to report ownership separately.
The form is signed by Ashley Grim on 03/26/2026 and reiterates that Vanguard and related accounts have no sole or shared voting or dispositive power over DocuSign common stock in this filing.
Roberts Brian Keith reported acquisition or exercise transactions in this Form 4 filing.
DocuSign director Brian Keith Roberts received a grant of 10,269 restricted stock units (RSUs). Each RSU represents the right to receive one share of DocuSign common stock. The award will vest in twelve equal quarterly installments over three years starting on March 5, 2026, as long as he remains a service provider. The RSUs have no traditional expiration date; they either vest on schedule or are canceled if vesting conditions are not met.